Corning partners with Merck, Pfizer for new injectable drug packaging project

July 21, 2017

Corning Inc., an American manufacturer of specialty glass and ceramics, is making a US$500 million investment with US pharmaceutical giants Merck and Pfizer to manufacture a new kind of glass for injectable drug vials, US President Donald Trump announced.

At a White House event, Trump said the effort will create nearly 1,000 jobs at facilities in New York and New Jersey and at a soon-to-be-determined site in the southeastern US.

The deal could eventually result in a total investment of US$4 billion and create around 4,000 jobs, Trump said, joined by the CEOs of Corning, Merck and Pfizer.

The commitments were made as part of Trump’s “Made in America” week, during which he has showcased American-made products and made an impassioned defense of his “America First” policies.

Corning said it developed the new type of glass in collaboration with the drug makers.

“This initiative will bring a key industry to our shores that for too long has been dominated by foreign countries. We’re moving more and more companies back into the United States,” Trump said.

After the remarks, Trump participated in the strength testing of the new Corning Valor Vial. Using a vise-like machine, he tested both an old vial which easily broke and the new Corning Valor Vial, struggling to break the latter despite putting far greater effort into it.


Category: Features, Pharmaceuticals

Comments are closed.